Cost-effectiveness analysis of letrozole versus tamoxifen as initial adjuvant therapy in hormone-receptor positive postmenopausal women with early breast cancer in the UK

被引：0

作者：

Karnon, J

Delea, TE

Papo, NL

Barghout, V

Thomas, SK

Johnston, SR

机构：

[1] Univ Sheffield, Sheffield, S Yorkshire, England

[2] Policy Anal Inc, Brookline, MA USA

[3] Novartis Pharmaceut UK Ltd, Camberley, England

[4] Novartis Pharmaceut Corp, Florham Pk, NJ USA

[5] Novartis Pharmaceut Corp, E Hanover, NJ USA

[6] Royal Marsden Hosp, London SW3 6JJ, England

来源：

关键词：

D O I：

10.1016/S1098-3015(10)67270-1

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A43 / A43

页数：1